Gestational Cytokines and the Developmental Expression of Obesity in Childhood

Akhgar Ghassabian1,2,3, Mady Hornig4, Zhen Chen5

  • 1Department of Pediatrics, School of Medicine, New York University, New York, New York, USA.

Obesity (Silver Spring, Md.)
|September 28, 2020
PubMed

Insights

Maternal prenatal inflammation, indicated by elevated cytokines like IL-1β, is linked to lower birth BMI but increased childhood obesity risk. These effects vary by age and sex, highlighting inflammation's role in obesity programming.

Area of Science:

  • Reproductive biology and immunology
  • Pediatric health and nutrition
  • Epidemiology of chronic diseases

Background:

  • Maternal immune system activity during pregnancy may influence fetal development and long-term health outcomes.
  • Childhood adiposity is a growing public health concern with complex etiological factors.
  • Understanding prenatal influences on childhood obesity is crucial for developing effective prevention strategies.

Purpose of the Study:

  • To investigate the association between maternal immune markers during pregnancy and childhood adiposity.
  • To determine if these associations differ at birth versus later in childhood.
  • To examine sex-specific differences in the relationship between maternal inflammation and child adiposity.

Main Methods:

  • Analysis of maternal serum cytokine levels (IL-1β, IL-6, TNF-α, IL-8, IL-10) during pregnancy in 1,366 participants.
  • Repeated measurement of children's Body Mass Index z scores (BMIz) from birth through age 8.
  • Application of linear mixed models to assess cumulative cytokine concentrations and their relation to child BMIz.

Main Results:

  • Higher maternal concentrations of IL-1β, IL-6, IL-8, and IL-10 were associated with lower BMIz at birth.
  • Elevated levels of IL-8 and IL-1β during pregnancy correlated with higher BMIz in infancy.
  • Maternal inflammation was linked to increased childhood BMIz, with sex-specific effects observed for TNF-α.

Conclusions:

  • Maternal prenatal inflammation plays a role in the developmental programming of obesity risk.
  • The impact of prenatal immune activity on adiposity is age- and sex-dependent.
  • Findings underscore the importance of the prenatal environment in shaping long-term metabolic health.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1000
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
36.3K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
96
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
15.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
134